SEARCH

SEARCH BY CITATION

References

  • 1
    Busuttil RA, Boussioutas A. Intestinal metaplasia: a premalignant lesion involved in gastric carcinogenesis. J. Gastroenterol. Hepatol. 2009; 24: 193201.
  • 2
    Malfertheiner P, Megraud F, O'Morain CA et al.; The European Heicobacter Study Group. Management of Helicobacter pylori infection-the Maastricht IV/Florence Consensus Report. Gut 2012; 61: 646664.
  • 3
    Mutoh H, Hakamata Y, Sato K et al. Conversion of gastric mucosa to intestinal metaplasia in Cdx2-expressing transgenic mice. Biochem. Biophys. Res. Commun. 2002; 294: 470479.
  • 4
    Suh E, Chen I, Taylor J, Traber PG. A homeobox protein related to caudal regulates intestine-specific gene transcription. Mol. Cell. Biol. 1994; 14: 73407351.
  • 5
    Silberg DG, Furth EE, Taylor JK, Schuck T, Chiou T, Traber PG. CDX1 protein expression in normal, metaplastic and neoplastic human alimentary tract epithelium. Gastroenterology 1997; 113: 478486.
  • 6
    Eda A, Osawa H, Yanaka I et al. Expression of homeobox gene CDX2 precedes that of CDX1 during progression of intestinal metaplasia. J. Gastroenterol. 2002; 37: 94100.
  • 7
    Silberg DG, Sullivan J, Kang E et al. Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. Gastroenterology 2012; 122: 689696.
  • 8
    Sakamoto H, Mutoh H, Hayakawa H, Sashikawa M, Sugano K. Cell lineage dynamics in the process leading to intestinal metaplasia. J. Gastroenterol. 2011; 46: 620628.
  • 9
    Mutoh H, Sakurai S, Satoh K et al. Cdx1 induced intestinal metaplasia in the transgenic mouse stomach: comparative study with Cdx2 transgenic mice. Gut 2004; 53: 14161423.
  • 10
    Mutoh H, Hayakawa H, Sakamoto H, Sashikawa M, Sugano K. Transgenic Cdx2 induces endogenous Cdx1 in intestinal metaplasia of Cdx2-transgenic mouse stomach. FEBS J. 2009; 276: 58215831.
  • 11
    Mutoh H, Sakurai S, Satoh K et al. Development of gastric carcinoma from intestinal metaplasia in Cdx2-transgenic mice. Cancer Res. 2004; 64: 77407747.
  • 12
    Tsukamoto T, Mizoshita T, Tatematsu M. Gastric-and-intestinal mixed-type intestinal metaplasia: aberrant expression of transcription factors and stem cell intestinalization. Gastric Cancer 2006; 9: 156166.
  • 13
    Mutoh H, Sashikawa M, Sugano K. Sox2 expression is maintained while gastric phenotype is completely lost in Cdx2-induced intestinal metaplasitic mucosa. Differentiation 2011; 81: 9298.
  • 14
    McDonald SAC, Greaves LC, Gutierrez-Gonzalez L et al. Mechanisms of field cancerization in the huma; n stomach: the expansion and spread of mutated gastric stem cells. Gastroenterology 2008; 134: 500510.
  • 15
    Lu J, Getz G, Miska EA et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834838.
  • 16
    Kang GH, Shim YH, Jung HY, Kim WH, Ro JY, Rhyu MG. CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res. 2001; 61: 28472851.
  • 17
    Ito K, Chuang LS, Ito T et al. Loss of Runx3 is a key event in inducing precancerous state of the stomach. Gastroenterology 2011; 140: 15361546.
  • 18
    Guthirrez-Gonzalez L, Graham TA, Rodriguez-Justo M et al. The clonal origins of dysplasia from intestinal metaplasia in the human stomach. Gastroenterology 2011; 140: 12511260.
  • 19
    Kamada T, Hata J, Sugiu K et al. Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori: results from a 9-year prospective follow-up study in Japan. Aliment. Pharmacol. Ther. 2005; 21: 11211126.
  • 20
    Take S, Mizuno M, Ishiki K et al. The long-term risk of gastric cancer after the successful eradication of Helicobacter pylori. J. Gastroenterol. 2011; 46: 318324.
  • 21
    Sanduleanu S, Jonkers D, De Bruine A, Hameeteman W, Stockbrugger RW. Double gastric infection with Helicobacter pylori and non-Helicobacter pylori bacteria during acid-suppressive therapy: increase of pro-inflammatory cytokines and development of atrophic gastritis. Aliment. Pharmacol. Ther. 2001; 15: 11631175.
  • 22
    Kaminishi M, Yamaguchi H, Nomura S et al. Endoscopic classification of chronic gastritis based on a pilot study by the research society for gastritis. Dig. Endosc. 2002; 14: 138151.
  • 23
    Uedo N, Ishihara R, Iishi H et al. A new method of diagnosing gastric intestinal metaplasia: narrow-band imaging with magnifying endoscopy. Endoscopy 2006; 38: 819824.
  • 24
    Osawa H, Yamamoto H, Miura Y et al. Diagnosis of extent of early gastric cancer using flexible spectral imaging color enhancement. World J. Gastrointest. Endosc. 2012; 4: 356361.
  • 25
    Osawa H, Miura Y, Ino Y, Satoh K, Yamamoto H, Sugano K. Blue laser imaging as a new endoscopic system can produce an excellent image of detailed microsctructure and microvasculare in superficial gastroduodenal neoplasm. Gut 2012; 61 (Suppl. 3): A240. (abstract).
  • 26
    Osawa H, Kita H, Ohnishi H et al. Helicobacter pylori eradication induces marked increase in H+/K+-adenosine triphosphatase expression without altering parietal cell number in human gastric mucosa. Gut 2006; 55: 152157.
  • 27
    Barros R, da Costa LT, Pinto-de-Sousa J et al. CDX2 autoregulation in human intestinal metaplasia of the stomach: impact on the stability of the phenotype. Gut 2011; 60: 290298.
  • 28
    Rugge M, Cassaro M, Di Mario F et al. Interdisciplinary group on gastric epithelial dysplasia. Gut 2003; 52: 11111116.
  • 29
    Tsukuma H, Oshima A, Narahara H, Morii T. Natural history of early gastric cancer: a non-concurrent, long-term, follow-up study. Gut 2000; 47: 618623.